EUROPE INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

EUROPE INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

There are various reasons for infertility, which include physiological, genetically induced disorders and at times may be self-induced as in the case of contraceptive surgeries. Infertility treatment is a multi-billion dollar industry. The key factors driving the market include raising awareness among couples about various infertility treatments, low-cost treatment options and an increase in new options for infertility treatment such as surrogacy.

EUROPE INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

Request free sample

There are various reasons for infertility, which include physiological, genetically induced disorders and at times may be self-induced as in the case of contraceptive surgeries. Infertility treatment is a multi-billion dollar industry. The key factors driving the market include raising awareness among couples about various infertility treatments, low-cost treatment options and an increase in new options for infertility treatment such as surrogacy.

The market is expected to lead throughout the forecast period of 2019-2027 by proliferating at a CAGR of 6.12%. The market is expected to lead throughout the forecast period of 2019-2027.

Medical tourism has been a key enabler for the growth of the infertility testing and treatment market. Fertility tourism for IVF, donor sperm, surrogate mothers and other infertility treatments are increasing due to a decrease in domestic supply and stringent government regulations in Europe.

The economies of the United Kingdom, Germany, France, Russia, and the Nordics are the major contributors to the market growth in Europe. The Nordic region has been a destination for fertility tourism for most couples from Europe, North America, Kenya, and Hong Kong. German infertility testing and treatment is the second fastest growing market in Europe. Increasing success rates of the IVF treatments within the region has led to significant growth in this market.

Europe houses 40% of the world’s IVF clinics, and this has proved to be a major contributory factor for the European infertility testing and treatment market’s success. The region has also witnessed substantial investments from global market leaders. The overall outlook for the European market looks promising as its superior IVF technology is attracting considerable investments from private equity investors. Also, DIY testing has increased the access and helped in reducing the costs for infertility testing and treatment. Both these factors are providing lucrative opportunities for market growth.

The major market players mentioned in the report are Vitrolife AB, MerckOrigio, Halotech DNA, Progyny, Thermo Fisher Scientific Inc., Genea, Irvine Scientific, Endo Pharmaceuticals, Andrology Solutions, Ferring Pharmaceuticals, Esco Micro PTE. Ltd., the Cooper Companies, Inc., Quest Diagnostic, and Ovascience.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • EUROPE IS THE LARGEST MARKET
      • IVF DOMINATES THE FEMALE TREATMENT MARKET
      • OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET
  1. MARKET OVERVIEW
    • MARKET DEFINITION
    • MARKET DRIVERS AND IMPACT
      • RISE IN INFERTILITY AND TREATMENT AWARENESS
      • MEDICAL TOURISM FOR FERTILITY TREATMENTS
      • SURROGACY LAWS ARE GETTING MORE DEFINED
      • HEALTHCARE ADVANCES HAVE FINETUNED FERTILITY TREATMENT
      • INCREASING EFFECTIVENESS OF TREATMENTS
      • HEALTHIER DONOR EGGS
      • INTRODUCTION OF NEW TESTING DEVICES
    • MARKET RESTRAINTS AND IMPACT
      • TREATMENT PROCEDURE OUT OF REACH TO MANY DUE TO COSTS INVOLVED
      • COUNTRY-WISE REGULATORY ISSUES
    • MARKET OPPORTUNITIES
      • REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE
      • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
      • DIY TESTING INCREASING ACCESS AND REDUCING COST
    • MARKET CHALLENGES
      • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
      • PERILS OF MULTIPLE PREGNANCIES
      • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS
        • DIET AND SUPPLEMENTS
        • ACUPUNCTURE
        • THERAPY
        • QIGONG
  1. INFERTILITY CAUSES
    • CAUSES OF MALE INFERTILITY
      • ABNORMALITY IN THE SPERM
      • ENVIRONMENTAL FACTORS
      • POOR HEALTH AND LIFESTYLE
    • CAUSES OF FEMALE INFERTILITY
      • OVULATION DISORDERS
      • DAMAGE TO FALLOPIAN TUBES
    • MORAL QUESTIONS
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
      • VASOVASOSTOMY AND VASOEPIDIDYMOSTOMY (VASECTOMY REVERSAL)
      • SPERM RETRIEVAL TREATMENT
      • MICROSURGICAL SPERM ASPIRATION (MESA)
      • TESTICULAR SPERM EXTRACTION (TESE)
      • VARICOCELE REPAIRS
      • ASSISTED REPRODUCTIVE TECHNIQUES (ART)
      • INTRAUTERINE INSEMINATION (IUI)
      • IN VITRO FERTILIZATION (IVF)
      • INTRACYTOPLASMIC SPERM INJECTION (ICSI)
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
      • IN VITRO FERTILIZATION
      • INTRAUTERINE INSEMINATION (IUI)
      • DRUG AND HORMONE THERAPIES
  1. EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END-USERS
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  3. EUROPE INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • UK
    • GERMANY
    • FRANCE
    • NORDICS
    • RUSSIA
  4. COMPANY PROFILES
    • ANDROLOGY SOLUTIONS
    • ENDO PHARMACEUTICALS
    • PROGYNY
    • FERRING PHARMACEUTICALS
    • GENEA
    • HALOTECH DNA
    • IRVINE SCIENTIFIC
    • MERCK
    • ORIGIO
    • OVASCIENCE
    • VITROLIFE AB
    • THERMO FISHER SCIENTIFIC INC.
    • THE COOPER COMPANIES, INC.
    • QUEST DIAGNOSTIC
    • ESCO MICRO PTE. LTD.

 

LIST OF TABLES

TABLE 1 EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)

TABLE 2 AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 3 EUROPE MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 4 EUROPE MALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5 PROS AND CONS OF DNA SHARING METHODS

TABLE 6 EUROPE FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 7 EUROPE FEMALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 8 EUROPE FEMALE INFERTILITY TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 9 AVERAGE COST OF SOME INFERTILITY TREATMENTS

TABLE 10 SOME COMMON DRUG THERAPIES

TABLE 11 EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 12 EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 13 COST OF IVF IN RUSSIA

 

LIST OF FIGURES                                                                

FIGURE 1 EUROPE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 2 MAJOR FERTILITY TREATMENT DESTINATION RANKING

FIGURE 3 CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN

FIGURE 4 RATE OF MULTIPLE DELIVERIES

FIGURE 5 CAUSES OF INFERTILITY

FIGURE 6 CAUSES OF INFERTILITY BASED ON GENDER

FIGURE 7 CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 8 UK INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 9 FERTILITY TREATMENT IN 2014

FIGURE 10 GERMANY INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 11 FRANCE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 12 NORDICS INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 13 RUSSIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

  1. EUROPE INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • UK
    • GERMANY
    • FRANCE
    • NORDICS
    • RUSSIA
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
      • VASOVASOSTOMY AND VASOEPIDIDYMOSTOMY (VASECTOMY REVERSAL)
      • SPERM RETRIEVAL TREATMENT
      • MICROSURGICAL SPERM ASPIRATION (MESA)
      • TESTICULAR SPERM EXTRACTION (TESE)
      • VARICOCELE REPAIRS
      • ASSISTED REPRODUCTIVE TECHNIQUES (ART)
      • INTRAUTERINE INSEMINATION (IUI)
      • IN VITRO FERTILIZATION (IVF)
      • INTRACYTOPLASMIC SPERM INJECTION (ICSI)
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
      • IN VITRO FERTILIZATION
      • INTRAUTERINE INSEMINATION (IUI)
      • DRUG AND HORMONE THERAPIES
  1. EUROPE INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now